Interventional Study on the Effects of Forest Therapy in Fibromyalgia Patients
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAzienda USL Toscana Nord Ovest
About this trial
The goal of this clinical trial is to evaluate if Forest therapy can reduce pain levels and improve the quality of life related to the level of pain perceived in fibromyalgia patients.
The main question it aims to answer is:
Does frequenting certified forest environments, according to the principles and methods of Forest Therapy, produce positive effects on chronic pain and the consumption of painkillers? The study is part of the "Forest Therapy Project as a Broad-Spectrum Tool for Patients Affected by Fibromyalgia" funded by the Tuscany Region as part of the Complementary Medicine program for the three-year period 2025-2027. The project will be carried out thanks to the collaboration with the National Research Council - Institute for BioEconomy (CNR-IBE)
Eligibility criteria
Qualifiers
18 years or older
diagnosis of fibromyalgia (diagnosed by a rheumatologist according to ACR criteria)
enrolled in the pain management program at the Intensive Care Unit of Cecina Hospital
under treatment with painkillers
Disqualifiers
Patients who have not been diagnosed with fibromyalgia
Diagnosis of neoplastic disease
Pregnant women
Allergies to pollen and/or grasses and/or insect bites
Trial design
Treatments tested in this trial
- Forest therapy
Treatment groups
70 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov